Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04172597
Title A Study of Poziotinib in Patients With EGFR or HER2 Activating Mutations in Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Spectrum Pharmaceuticals, Inc

Advanced Solid Tumor

breast cancer

colorectal cancer

malignant glioma



Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST